<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="99228">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02021058</url>
  </required_header>
  <id_info>
    <org_study_id>13.10.INF</org_study_id>
    <nct_id>NCT02021058</nct_id>
  </id_info>
  <brief_title>Study in Unsettled Infants Experiencing Feeding Intolerance</brief_title>
  <official_title>Effect of an Experimental Infant Formula in Unsettled Infants Experiencing Feeding Intolerance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <authority>Hong Kong: Joint CUHK-NTEC Clinical Research Ethics Committee</authority>
    <authority>Thailand: Ministry of Public Health</authority>
    <authority>Thailand: Ethical Committee</authority>
    <authority>Philippines : Food and Drug Administration</authority>
    <authority>Philippines: Ethics Committee</authority>
    <authority>Taiwan: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multinational, multicenter, clinical trial. To evaluate the effect of an experimental
      formula on GI symptoms and associated behaviors in unsettled infants with parent-reported
      feeding intolerance
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the present study is therefore to evaluate the effect of an experimental
      formula in an unsettled formula-fed infant population whose parents are considering
      switching formulas due to perceived feeding intolerance.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Changes from baseline to 14 days in fuss-cry behavior</measure>
    <time_frame>from baseline to 14 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>fuss-cry behavior per 24 hours</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline to 14 days in GI symptoms</measure>
    <time_frame>from baseline to 14 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Feeding Disorder</condition>
  <arm_group>
    <arm_group_label>Experimental Formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental Formula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Formula</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard Infant formula</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental Formula</intervention_name>
    <description>Experimental formula</description>
    <arm_group_label>Experimental Formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard control formula</intervention_name>
    <description>Standard Infant formula</description>
    <arm_group_label>Standard Formula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Full term infants, singleton, healthy at birth

          2. Infants of parent(s)/LAR who have previously made the decision to exclusively formula
             feed their infant.

          3. Infants exclusively consuming a standard formula for a minimum of 3 consecutive days
             prior to enrolment.

          4. Infant's parent(s)/LAR are of legal age of consent and are willing and able to fulfil
             the requirements of the study protocol.

        Exclusion Criteria:

          1. Infants who are consuming any amount of supplemental human milk

          2. Infants who are consuming weaning foods or beverages other than infant formula

          3. Infants with known cow's milk allergy or family history of siblings with documented
             cow's milk protein intolerance/allergy

          4. Infants who have a medical condition or history that could cause or contribute to
             feeding intolerance

          5. Infants who received any other investigational intervention or who have  participated
             in another clinical trial prior to enrolment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>90 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Associate Professor Boosba Vivatvakin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pediatric Department, Faculty of Medicine, Chulalongkorn University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dr. Chung Mo CHOW</name>
      <address>
        <city>Shatin, N.T.</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Chung Mo CHOW, MD</last_name>
      <phone>852 2632 2851</phone>
      <email>ccm250@ha.org.hk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Shatin, New Territories</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Professor Ellis Kam Lun HON</last_name>
      <phone>852 2632 2982</phone>
      <email>ehon@cuhk.edu.hk</email>
    </contact>
    <investigator>
      <last_name>Professor Ellis Kam Lun HON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dr. Maria Rosario Capeding</name>
      <address>
        <city>Filinvest Corporate City</city>
        <state>Alabang, Muntinlupa City</state>
        <zip>1780</zip>
        <country>Philippines</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Maria Rosario Capeding, MD</last_name>
      <phone>Capeding</phone>
      <email>lerosecap@yahoo.com.ph</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dr. Hung Chang Lee</name>
      <address>
        <city>Tamsui District, New Taipei City,Taiwan</city>
        <state>New Taipei City,Taiwan</state>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Hung Chang Lee, MD</last_name>
      <phone>886 3 6119595</phone>
      <phone_ext>2469</phone_ext>
      <email>ped2435@ms2.mmh.org.tw</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dr. Re Yin Lien</name>
      <address>
        <city>Hsiang, Taoyan Hsien</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Re Yin Lien, MD</last_name>
      <phone>886 3 3281200</phone>
      <phone_ext>8203</phone_ext>
      <email>reyin1@adm.cgmh.org.tw</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dr. Hung Chang Lee</name>
      <address>
        <city>Tapei City</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Hung Chang Lee, MD</last_name>
      <phone>886 3 6119595</phone>
      <phone_ext>2469</phone_ext>
      <email>ped2435@ms2.mmh.org.tw</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Assoc. Prof. Boosba Vivatvakin</name>
      <address>
        <city>Pratumwan, Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hong Kong</country>
    <country>Philippines</country>
    <country>Taiwan</country>
    <country>Thailand</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 19, 2013</lastchanged_date>
  <firstreceived_date>November 22, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
